Drug Trial Radar · NCT05422508
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
Last checked: Nov 19, 2026Latest source record: Jan 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
230
Planned (sponsor's estimate)
Start
Jul 5, 2022
Primary completion
Jun 2025
Study completion Jun 2027
Sponsor
- Lead sponsor
- Green Cross CorporationIndustry
- Sponsor type
- Industry
- First posted
- Jun 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 4 years, up to 6 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
* Primary objective is to assess the safety of MG1111 until Day 42 using as 2nd vaccination * Secondary objective to assess the immunogenicity and safety of MG1111 using as 2nd vaccination
Conditions
- Varicella
Interventions
MG1111 (BARICELA)Biological
0.5ml, single dose, subcutaneous injection
VARIVAXBiological
0.5ml, single dose, subcutaneous injection
SuduvaxBiological
0.5ml, single dose, subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of fever (temperature ≥39.0℃)Time frame: within 7 days
- Solicited local / systemic adverse eventsTime frame: within 7 days
- Unsolicited adverse eventsTime frame: within 42 days
- Vital signs (blood pressure, pulse rate, respiration rate and body temperature)Time frame: within 42 days
- Incidence of fever (temperature ≥39.0℃)Time frame: within 42days
- Physical examinations (Cardiovascular, respiratory, gastrointestinal, liver, metabolic/endocrine, kidney, reproductive, musculoskeletal and nervous system, head/neck, and skin)Time frame: within 42 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Korea University Ansan Hospital
Ansan, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.